ArticleJournal of experimental & clinical cancer research : CR2023

Combination of RUNX1 inhibitor and gemcitabine mitigates chemo-resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress.

Chunhua She et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.